Sexual and reproductive health is not “one size fits all.” As markets become more mature, DKT is better able to expand the number of choices available to keep pace with the evolving needs of consumers. Some of the ways that DKT promotes choice through our growing product portfolio are highlighted below.   

• DMPA-SC (subcutaneous depot medroxyprogesterone acetate) is a self-injectable contraceptive that comes prefilled for self-administration in the comfort of a client’s home.
• HIV self-test kits  empowering people with the means of learning their HIV status using a painless sample collected by swabbing the gums. 
• IUD varieties are growing in number, allowing users to pick and choose based on their needs. In addition to traditional copper (non-hormonal) IUDs, DKT offers a hormonal IUD, “sleek” IUDs, and post-partum IUDs.    
• Levoplant, a two-rod contraceptive implant prequalified by the World Health Organization, offers a highly affordable long-acting reversible contraceptive option.
• Oral contraceptive pills come in a variety of formulations, including some that offer non-contraceptive benefits, such as controlling acne. 
• Mifepristone, when used in combination with misoprostol, is an effective way to end an early pregnancy or manage a miscarriage. In some countries, it can be self-administered in the home. 

DKT works with research and development partners to expand this list and bring more choices to clients around the world.